Literature DB >> 21333897

Epidemiology of IBS.

Rok Seon Choung1, G Richard Locke.   

Abstract

Irritable bowel syndrome (IBS) is a common functional gastrointestinal (GI) disorder. Because not everyone needs to seek care, population-based studies are needed to truly understand the epidemiology of IBS. About 10% of the population has IBS at any one time and about 200 people per 100,000 will receive an initial diagnosis of IBS over the course of a year. IBS patients are more frequently younger in age, and a female predominance has been observed in Western countries and tertiary care settings. IBS patients commonly report overlapping upper GI, as well as a variety of non-GI, complaints.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21333897     DOI: 10.1016/j.gtc.2010.12.006

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  50 in total

1.  Bone: Risk of osteoporotic fractures in irritable bowel syndrome.

Authors:  Juliet E Compston
Journal:  Nat Rev Endocrinol       Date:  2012-11-20       Impact factor: 43.330

2.  Second-Generation Biomarker Testing for Irritable Bowel Syndrome Using Plasma Anti-CdtB and Anti-Vinculin Levels.

Authors:  Walter Morales; Ali Rezaie; Gillian Barlow; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2019-05-31       Impact factor: 3.199

Review 3.  Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?

Authors:  Eamonn M M Quigley
Journal:  Therap Adv Gastroenterol       Date:  2016-03       Impact factor: 4.409

Review 4.  Treatment of abdominal pain in irritable bowel syndrome.

Authors:  Tim Vanuytsel; Jan F Tack; Guy E Boeckxstaens
Journal:  J Gastroenterol       Date:  2014-05-21       Impact factor: 7.527

5.  Irritable bowel syndrome: current and emerging treatment options.

Authors:  Lauren Peyton; Joy Greene
Journal:  P T       Date:  2014-08

6.  Irritable bowel syndrome may be associated with maternal inheritance and mitochondrial DNA control region sequence variants.

Authors:  Miranda A L van Tilburg; Essam A Zaki; Thangam Venkatesan; Richard G Boles
Journal:  Dig Dis Sci       Date:  2014-02-06       Impact factor: 3.199

Review 7.  Close association between intestinal microbiota and irritable bowel syndrome.

Authors:  W-T Fan; C Ding; N-N Xu; S Zong; P Ma; B Gu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-07       Impact factor: 3.267

8.  Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome.

Authors:  Anne Line Engsbro; C Rune Stensvold; Henrik V Nielsen; Peter Bytzer
Journal:  Am J Trop Med Hyg       Date:  2012-10-22       Impact factor: 2.345

Review 9.  Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target?

Authors:  Xiao-juan Xu; Liang Liu; Shu-kun Yao
Journal:  J Zhejiang Univ Sci B       Date:  2016-01       Impact factor: 3.066

Review 10.  Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions.

Authors:  Niall P Hyland; Eamonn M M Quigley; Elizabeth Brint
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.